No Sales BS, please. Just the facts, ma'am.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is it the install in the Netherlands or Kuwait? Or elsewhere?
CVD and stroke number 1 causes of death? More than a market niche. It's like finding the cure to the Black Death.
Ah then I'm a moralist indeed. Go LXGTF!
It's good to include these patents for LXGTF in your DD.
Actually he was right. Great call!
Spread needs to tighten. I'd like to see that Ask get hit again but good and leave no doubt.
Churn Churn Churn, Vol, Vol, Vol. Rome wasn't built in a day. You don't build a beautiful opportunity like LXGTF with one spike of the chart. Nice steady accumulation.
"Go Go Gadget Endothelial Monitor!" LOL LXGTF
RAKR back at a buck and green. GO RAKR!
A good whack at Ask would do it.
"Premarket data demonstrate that the probability of serious harm is low" Huh, you know that's true if this was a surgically implanted device or something it would require a lot more testing. The very functionality of LXGTF as a wearable external device means that we really are alot closer to market than I first realized. Kudos to the FDA. This FastTrack program really is a win for common sense, a win for the public at large and a win for LXGTF longs.
Point 9 is FDA approval. LXGTF is an FDA regulated product using the 510 (k) premarket approval process. That means the market is likely right around the corner.
That's exactly why we see this consistent steady chart. LXGTF is not flashy, just following through on what they said they would and long investor's have taken notice.
LXGTF: Nice consistent gainer. Great volume in a gentle chart.
That Dr. Jonathan Maltz is the kind of brain you think might cure cancer one day. Absolutely brilliant. LXGTF is on sound scientific footing with him on board.
.45 coming up soon.
Now that accumulation is really built up for another breakout. All systems buy for sure.
Beaut chart. You can see where it reset after being a little oversold. But that resistance at .42 stopped it.
Looking forward to early morning breakout for LXGTF.
Morning RAKR! Time for the climb!
Yes sir! Right on the cusp of clinical trials a great place to be with LXGTF.
Good Morning LXGTF! Blast off coming!
Over .50 just around the bend for LXGTF.
I'm in for long. Of course you can sell if you like. Plenty of longs here to catch whatever is shaken out. This float won't wander far.
All things considered. Had a dip in the morning but Longs have this on a short leash and snap up RAKR shaked out discounts right away. Very buyoant.
This chart is big news to me. You can see where it reset a few days ago and a big pool if accumulation is getting ready to break flimsy resistance LXGTF
https://www.barchart.com/stocks/quotes/LXGTF/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=HLMA(10,8)&sym=LXGTF&grid=1&height=210&studyheight=100
Great level to re-up.
LXGTF: best ticker you never heard about.
Breakout coming at .46 IMO.
LXGTF definitely the tortoise that wins the race. LONGS will be sitting pretty when Heart Sentry clinical trials are done.
Agreed. Look at the trades you can see a massive pool of support building that will push LXGTF to the next level.
Any avg. volume day for LXGTF is still a chunk of change. The consistent volume and steady uptick here is so attractive.
APRU nice climb. Up 46%.
QSIM up 20% on high vol.
As Buffet the Oracle of Omaha says the way to wealth in stocks is to be greedy when others are fearful and fearful when others are greedy. RAKR under sold atm.
RAKR buy on the dips.
When we establish a new support at .44, it should trigger a nice green run imo.
You can't keep RAKR down...Dutch military contracts smell like profit.
Not surprising when you factor in first HeartSentry monitors already delivered and they stand at the cusp of clinical trials and fast tracked FDA approval.
Wow. Look at that volume. Are we going to trade more volume even then yesterday?